Paper39057463
Stimulus-Responsive Hydrogels for Targeted Cancer Therapy.
Solanki R and 1 other. Gels, 2024. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Stimulus-Responsive Hydrogels for Targeted Cancer Therapy. Papers, record 39057463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39057463
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References138
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37989251 | pH-Responsive Injectable Multifunctional Pluronic F127/Gelatin-Based Hydrogels with Hydrogen Production for Treating Diabetic Wounds. | ACS Appl Mater Interfaces | 2023 | https://conductscience.org/library/papers/37989251 | PubMed |
| 2 | 33231137 | Multi-stimuli-responsive, liposome-crosslinked poly(ethylene glycol) hydrogels for drug delivery. | J Biomater Sci Polym Ed | 2021 | https://conductscience.org/library/papers/33231137 | PubMed |
| 3 | 32254530 | Biodegradable pH-responsive hydrogels for controlled dual-drug release. | J Mater Chem B | 2018 | https://conductscience.org/library/papers/32254530 | PubMed |
| 4 | 30920531 | Poly(N-isopropylacrylamide) and Copolymers: A Review on Recent Progresses in Biomedical Applications. | Gels | 2017 | https://conductscience.org/library/papers/30920531 | PubMed |
| 5 | 23638642 | Injectable nano-network for glucose-mediated insulin delivery. | ACS Nano | 2013 | https://conductscience.org/library/papers/23638642 | PubMed |
| 6 | 27455412 | Injectable and Glucose-Responsive Hydrogels Based on Boronic Acid-Glucose Complexation. | Langmuir | 2016 | https://conductscience.org/library/papers/27455412 | PubMed |
| 7 | 32261508 | Injectable and redox-responsive hydrogel with adaptive degradation rate for bone regeneration. | J Mater Chem B | 2014 | https://conductscience.org/library/papers/32261508 | PubMed |
| 8 | 33778186 | Cyclophosphamide loaded thermo-responsive hydrogel system synergize with a hydrogel cancer vaccine to amplify cancer immunotherapy in a prime-boost manner. | Bioact Mater | 2021 | https://conductscience.org/library/papers/33778186 | PubMed |
| 9 | 35457239 | Enzyme-Responsive Hydrogels as Potential Drug Delivery Systems-State of Knowledge and Future Prospects. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35457239 | PubMed |
| 10 | 30970818 | pH Sensitive Hydrogels in Drug Delivery: Brief History, Properties, Swelling, and Release Mechanism, Material Selection and Applications. | Polymers (Basel) | 2017 | https://conductscience.org/library/papers/30970818 | PubMed |
| 11 | 37688994 | Artificial intelligence in cancer diagnosis and therapy: Current status and future perspective. | Comput Biol Med | 2023 | https://conductscience.org/library/papers/37688994 | PubMed |
| 12 | 34973264 | Cytocompatible drug delivery hydrogels based on carboxymethylagarose/chitosan pH-responsive polyelectrolyte complexes. | Int J Biol Macromol | 2022 | https://conductscience.org/library/papers/34973264 | PubMed |
| 13 | 33259851 | Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: A review. | J Control Release | 2021 | https://conductscience.org/library/papers/33259851 | PubMed |
| 14 | 34636386 | Near-infrared light-responsive hybrid hydrogels for the synergistic chemo-photothermal therapy of oral cancer. | Nanoscale | 2021 | https://conductscience.org/library/papers/34636386 | PubMed |
| 15 | 33207715 | Fundamental Concepts of Hydrogels: Synthesis, Properties, and Their Applications. | Polymers (Basel) | 2020 | https://conductscience.org/library/papers/33207715 | PubMed |
| 16 | 31423670 | Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation. | Adv Mater | 2020 | https://conductscience.org/library/papers/31423670 | PubMed |
| 17 | 38490383 | Enhanced delivery of doxorubicin for breast cancer treatment using pH-sensitive starch/PVA/g-C3N4 hydrogel. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/38490383 | PubMed |
| 18 | 38392019 | Advances in Cancer Research: Current and Future Diagnostic and Therapeutic Strategies. | Biosensors (Basel) | 2024 | https://conductscience.org/library/papers/38392019 | PubMed |
| 19 | 34793135 | Redox-Responsive Hydrogels with Decoupled Initial Stiffness and Degradation. | Biomacromolecules | 2021 | https://conductscience.org/library/papers/34793135 | PubMed |
| 20 | 35099927 | pH/Glucose Dual Responsive Metformin Release Hydrogel Dressings with Adhesion and Self-Healing via Dual-Dynamic Bonding for Athletic Diabetic Foot Wound Healing. | ACS Nano | 2022 | https://conductscience.org/library/papers/35099927 | PubMed |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42967077 | Protein Lactylation in Cancer: From Mechanisms to Therapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42967077 | PubMed |
| 42929940 | Multi-Stimuli-Responsive Hydrogels: From Strategic Design to Biomedical Applications. | Gels | 2026 | https://conductscience.org/library/papers/42929940 | PubMed |
| 42844427 | Stimuli-Responsive Hydrogel Systems for Breast Cancer Therapy: Advances in Targeted Delivery and Tumor Microenvironment Modulation. | AAPS PharmSciTech | 2026 | https://conductscience.org/library/papers/42844427 | PubMed |
| 42751213 | Bio-Polymers Based Functionalized Hydrogel Carriers for Targeted Oncology Therapies: Current Progress and Future Perspectives. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42751213 | PubMed |
| 42737106 | Localized Hydrogel-Based Therapeutics: A Strategic Approach to Mitigating Postoperative Recurrence in Breast Cancer. | Polymers (Basel) | 2026 | https://conductscience.org/library/papers/42737106 | PubMed |
| 42699756 | Local Nanomedicine and Nano-Enabled Biomaterials After Glioblastoma Resection. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42699756 | PubMed |
| 42644923 | Cell-Type-Tailored Hydrogels for Adoptive Cell Therapy in Cancer. | Gels | 2026 | https://conductscience.org/library/papers/42644923 | PubMed |
| 42514881 | Stimuli-Responsive Nanocarriers as Next-Generation on-Demand Drug Delivery Systems for Cancer Therapy: Mechanistic Insights, Trigger Modalities, and Translational Challenges. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514881 | PubMed |
| 42513150 | Intelligent Hydrocolloid-Based Delivery Systems: Innovations in Pharmacy and Cosmetics. | Molecules | 2026 | https://conductscience.org/library/papers/42513150 | PubMed |
| 42505275 | Research Progress on Natural Polysaccharide Hydrogels in the Diagnosis and Treatment of Colorectal Cancer. | Gels | 2026 | https://conductscience.org/library/papers/42505275 | PubMed |
| 42505266 | Hydrogels Activated with Plant Extracts/Bioactive Compounds for Cancer Treatment: From Design to Application. | Gels | 2026 | https://conductscience.org/library/papers/42505266 | PubMed |
| 42210822 | Clinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics. | Chem Soc Rev | 2026 | https://conductscience.org/library/papers/42210822 | PubMed |
| 42194071 | Biomolecular Interfaces in Targeted Nano-Drug Delivery: Molecular Recognition, Signaling Modulation, and Translational Pathways. | Biomolecules | 2026 | https://conductscience.org/library/papers/42194071 | PubMed |
| 41928316 | Bridging biomaterials and immunotherapy: hydrogel strategies for next-generation CAR-T cell treatment. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/41928316 | PubMed |
| 41901842 | Hydrogels-Advanced Polymer Platforms for Drug Delivery. | Polymers (Basel) | 2026 | https://conductscience.org/library/papers/41901842 | PubMed |
| 41900770 | Microbiome-Responsive Hydrogels: From Biological Cues to Smart Biomaterials. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41900770 | PubMed |
| 41869409 | Recent Advances in Nanoscale Sprayable Hydrogels for Cancer Management: Nanoparticle-Loaded Formulations for Therapy and Prevention. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41869409 | PubMed |
| 41744970 | Recent Advances in Smart Stimulus-Responsive Hydrogels for Precision Drug Delivery in Tumours. | Gels | 2026 | https://conductscience.org/library/papers/41744970 | PubMed |
| 41684277 | pH/ROS-Responsive Injectable Hydrogel Co-Loaded with B7-H3 Blocker and NETs Suppressor Boosts OSCC Synergistic Immunotherapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41684277 | PubMed |
| 41661421 | Smart nanoparticle delivery systems for curcumin: a targeted strategy to enhance anticancer efficacy and bioavailability. | J Mater Sci Mater Med | 2026 | https://conductscience.org/library/papers/41661421 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39057463
GET https://conductscience.org/api/papers/v1/39057463/references?page=2